Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Kinetic oscillation stimulation for chronic migraine is associated with a significant decrease in monthly headache days vs ...
China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results